Quick Answer
Kraig Biocraft Laboratories, Inc. reported R&D Expense of $165.8 thousand for fiscal year 2025.
Kraig Biocraft Laboratories, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $165.8K | +0.8% |
| 2024 | $164.4K | -30.9% |
| 2023 | $237.9K | +34.8% |
| 2022 | $176.4K | -10.8% |
| 2021 | $197.7K | +123.5% |
| 2020 | $88.5K | -60.3% |
| 2019 | $223.1K | +50.6% |
| 2018 | $148.1K | -42.8% |
| 2017 | $258.9K | -34.8% |
| 2016 | $397.1K | -8.1% |
| 2015 | $432.0K | -1.7% |
| 2014 | $439.5K | -10.2% |
| 2013 | $489.4K | +5.2% |
| 2012 | $465.3K | +85.7% |
| 2011 | $250.6K | +77.3% |
| 2010 | $141.3K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.2K | -63.0% | -85.5% |
| June 30, 2025 | $63.9K | +29.3% | +167.6% |
| March 31, 2025 | $23.9K | -18.9% | -4.4% |
| September 30, 2024 | $25.0K | -36.2% | -49.5% |
| June 30, 2024 | $49.4K | -13.4% | +67.9% |
| March 31, 2024 | $29.4K | -57.4% | -24.8% |
| September 30, 2023 | $39.1K | -37.0% | -31.4% |
| June 30, 2023 | $57.0K | +14.4% | -17.5% |
- Kraig Biocraft Laboratories, Inc. showed an increase of +0.8% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, Kraig Biocraft Laboratories, Inc.’s r&d expense has grown by 17.3% (from $141.3 thousand to $165.8 thousand).
- The most recent figure is from Kraig Biocraft Laboratories, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: